Why the study?
Does L-arginine or spironolactone reverse left ventricular hypertrophy and aortic remodelling in L-NAME-induced hypertensive rats?
Population
Male adult Wistar rats with N(omega)-nitro-L-arginine methyl ester (L-NAME)-induced hypertension
Comparison
L-arginine or spironolactone for 3 weeks vs Spontaneous reversion and healthy controls
Design
Preclinical
Follow-up
7 weeks (4 weeks induction + 3 weeks recovery)
Authors
Loading...
Should not yet inform human hypertension therapy; extends evidence on selective regression of LVH versus fibrosis in this model.
Does L-arginine or spironolactone reverse left ventricular hypertrophy and aortic remodelling in L-NAME-induced hypertensive rats?
In L-NAME-induced hypertensive rats, regression of LVH and hypertension occurs independently of NO-synthase restoration, while LV fibrosis and aortic remodeling are more resistant to regression.
Paulis et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: